Visit the website of BridgeBio Pharma (NDQ:BBIO), and you'll find it describes itself as 'a unique biotechnology company advancing genetic medicines via a ...
Ascendis Pharma (NDQ:ASND) has a portfolio of drugs that could be the most important to hit the market since BioMarin's Voxzogo (vosoritide). This became one ...
North America CEO Kristie Keast is leaving at the end of October 2026, with Sue Stark stepping in as interim leader.
NEXTDC (ASX:NXT) has cut FY27 revenue and EBITDA guidance by around A$140m after Jemena suspended power works at its M3 ...
LinQ Minerals (ASX:LNQ) reports 429m of visual mineralisation at Gidginbung South, with assays due in 6 to 8 weeks to confirm ...
Sigma Healthcare (ASX:SIG) posted 12.1% Chemist Warehouse sales growth and 9.8% like-for-like after cycling the GLP-1 boost ...
SpaceX (NSDQ:SPCX) delivered US$14.6bn Q3 revenue as Super Intelligence turned profitable, but investors still face a ...
SpaceX (SPCX) beats Q3 estimates as AI revenue surges 830% to US$7.56 billion. Discover what drove the earnings jump and why ...
Most investors meet a technology company through its financial statements. Revenue growth, gross margin, cash conversion — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results